Vicapsys Life Sciences, Inc.
VICP
$1.77
$0.5039.37%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.35M | -1.35M | -1.30M | -1.18M | -1.08M |
| Total Depreciation and Amortization | -- | -- | -- | -- | 7.80K |
| Total Amortization of Deferred Charges | 101.90K | 141.40K | 142.80K | 115.00K | 63.60K |
| Total Other Non-Cash Items | 86.30K | 104.90K | 86.30K | 20.70K | 423.00K |
| Change in Net Operating Assets | 1.03M | 913.10K | 651.60K | 628.70K | 252.70K |
| Cash from Operations | -125.70K | -192.70K | -417.00K | -417.60K | -332.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 106.50K | -78.40K | 266.80K | 266.80K | 290.30K |
| Total Debt Repaid | -47.40K | -47.40K | -41.20K | -41.20K | -- |
| Issuance of Common Stock | 0.00 | 36.80K | 136.80K | 136.80K | 136.80K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 102.70K | 50.50K | 50.50K | 50.50K | -67.20K |
| Cash from Financing | 161.70K | -38.60K | 412.80K | 412.80K | 359.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.10K | -231.20K | -4.10K | -4.70K | 27.30K |